Aclarion Inc (ACON) Stock Price, Quote & News

Company Profile

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs whi...

Industry: Health Information Services

Sector: Healthcare

Phone: 833 275 2266

Website: www.aclarion.com

Address:

8181 Arista Place, Suite 100, Broomfield, United States

gapureau Nov. 14 at 5:19 PM

$NIVF Look at chart of these stocks. In addition to SP going down, down, down, what else do they all have in common? Financing deal with White Lion Capital. However, their type financing "is not unique". Just that if you see their name, be prepared for the likely outcome. $BLMZ, $RELI, $AUUD, $ACON . Probably more but you get the idea. GLTA!

1 · Reply

TrkDvr Nov. 14 at 1:07 PM

$ACON Prizes aren't a line item on a P&L - sales are. Lets hear how you're fixing this problem.

0 · Reply

Putnik Nov. 13 at 9:50 PM

$ACON

0 · Reply

Tellsome1 Nov. 13 at 7:33 PM

$ACON

0 · Reply

TurskaInTar Nov. 13 at 2:19 PM

$ACON Funny how the price is always kept close to bid to look bad/red...and the ask is now at 9.92 😂 feels like manipulation to get shares cheap or because of shorting.

0 · Reply

brptrader Nov. 13 at 11:33 AM

$ACON or should i say lack of earnings

0 · Reply

brptrader Nov. 13 at 11:33 AM

$ACON cant believe no one watching this didnt post earnings report from yesterday. Weird.

0 · Reply

isaacwilliams33 Nov. 11 at 6:43 PM

$ACON $TMC $ORIS $UAMY $ELDN

0 · Reply

Putnik Nov. 10 at 11:42 PM

$ACON can’t wait till they send it to $17 to $20

1 · Reply

TurskaInTar Nov. 10 at 9:03 PM

$ACON they really worked hard to keep it at 7.24 today😂

0 · Reply

Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

Oct 9, 2025, 6:00 AM EDT - 5 weeks ago

Aclarion to Present at the LD Micro Main Event XIX

Jun 24, 2025, 7:00 AM EDT - 5 months ago

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

May 20, 2025, 6:00 AM EDT - 6 months ago

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

May 12, 2025, 7:34 AM EDT - 6 months ago

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Apr 29, 2025, 6:00 AM EDT - 7 months ago

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Apr 23, 2025, 6:00 AM EDT - 7 months ago

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Apr 21, 2025, 6:00 AM EDT - 7 months ago

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Apr 9, 2025, 7:00 AM EDT - 7 months ago

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Apr 2, 2025, 6:00 AM EDT - 8 months ago

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Mar 31, 2025, 7:00 AM EDT - 8 months ago

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Mar 13, 2025, 9:25 AM EDT - 8 months ago

Aclarion Provides Shareholder Update

Mar 6, 2025, 9:35 AM EST - 9 months ago

Aclarion Announces Expansion Plans with RadNet Affiliates in New York and New Jersey

Mar 3, 2025, 6:00 AM EST - 9 months ago

Aclarion Announces First Commercial Agreement with Scripps Health

Feb 20, 2025, 6:00 AM EST - 9 months ago

Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit

Feb 11, 2025, 7:58 AM EST - 9 months ago

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Feb 6, 2025, 7:23 AM EST - 10 months ago

Aclarion Announces Northwestern Medicine as First CLARITY Trial Site

Feb 4, 2025, 7:23 AM EST - 10 months ago

Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded

Nov 21, 2024, 8:00 AM EST - 1 year ago

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Nov 14, 2024, 5:00 PM EST - 1 year ago

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Oct 10, 2024, 7:00 AM EDT - 1 year ago

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 27, 2024, 6:57 AM EDT - 1 year ago

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

Sep 13, 2024, 8:30 AM EDT - 1 year ago

PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology

Sep 12, 2024, 6:57 AM EDT - 1 year ago

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

Sep 10, 2024, 6:57 AM EDT - 1 year ago

Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial

Sep 5, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Surgeon Partnership to Apply Nociscan's AI Technology to Personal Injury and Workers Compensation Market

Aug 29, 2024, 6:57 AM EDT - 1 year ago

Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New Jersey

Aug 21, 2024, 7:57 AM EDT - 1 year ago

Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan's AI Generated Biomarker Data Changes Surgical Treatment Plans

Aug 15, 2024, 9:48 AM EDT - 1 year ago

Aclarion to Present at August 20th Virtual Investor Summit Microcap Event

Aug 14, 2024, 8:08 AM EDT - 1 year ago

Aclarion Announces First Commercial Agreement in Michigan

Aug 13, 2024, 9:07 AM EDT - 1 year ago

Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UK

Jul 9, 2024, 7:00 AM EDT - 1 year ago

Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK

Jun 26, 2024, 8:30 AM EDT - 1 year ago

Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UK

Jun 25, 2024, 8:30 AM EDT - 1 year ago

Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater London

Apr 25, 2024, 9:14 AM EDT - 1 year ago

Aclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain

Feb 27, 2024, 3:22 PM EST - 1 year ago

Aclarion Announces Closing of $3.0 Million Public Offering

Feb 26, 2024, 9:15 AM EST - 1 year ago

Aclarion Announces Pricing of $3.0 Million Public Offering

Feb 5, 2024, 8:00 AM EST - 1 year ago

Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic Partnership

Jan 22, 2024, 8:00 AM EST - 1 year ago

Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MD

Nov 27, 2023, 8:00 AM EST - 2 years ago

Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams

Nov 6, 2023, 8:00 AM EST - 2 years ago

Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

Oct 24, 2023, 8:45 AM EDT - 2 years ago

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

Oct 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

Aug 25, 2023, 4:10 PM EDT - 2 years ago

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

Jun 14, 2023, 11:27 AM EDT - 2 years ago

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

Jun 8, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

May 30, 2023, 7:30 AM EDT - 2 years ago

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

May 23, 2023, 7:30 AM EDT - 2 years ago

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

May 23, 2023, 7:00 AM EDT - 2 years ago

Aclarion, Inc. Announces Delayed 10-Q Filing

gapureau Nov. 14 at 5:19 PM

1 · Reply

TrkDvr Nov. 14 at 1:07 PM

$ACON Prizes aren't a line item on a P&L - sales are. Lets hear how you're fixing this problem.

0 · Reply

Putnik Nov. 13 at 9:50 PM

$ACON

0 · Reply

Tellsome1 Nov. 13 at 7:33 PM

$ACON

0 · Reply

TurskaInTar Nov. 13 at 2:19 PM

$ACON Funny how the price is always kept close to bid to look bad/red...and the ask is now at 9.92 😂 feels like manipulation to get shares cheap or because of shorting.

0 · Reply

brptrader Nov. 13 at 11:33 AM

$ACON or should i say lack of earnings

0 · Reply

brptrader Nov. 13 at 11:33 AM

$ACON cant believe no one watching this didnt post earnings report from yesterday. Weird.

0 · Reply

isaacwilliams33 Nov. 11 at 6:43 PM

$ACON $TMC $ORIS $UAMY $ELDN

0 · Reply

Putnik Nov. 10 at 11:42 PM

$ACON can’t wait till they send it to $17 to $20

1 · Reply

TurskaInTar Nov. 10 at 9:03 PM

$ACON they really worked hard to keep it at 7.24 today😂

0 · Reply

Apes_Strong Nov. 10 at 8:46 PM

$ACON pray tell This thing was squeezing a few weeks ago Trading over $12 They have $13 million in cash and no debt Ample working capital for the next year Why did our Jeff decide to sabotage the rally by issuing $2,500,000 of stock with no no rhyme or reason

0 · Reply

isaacwilliams33 Nov. 7 at 2:01 AM

$ACON who is going short at this price, Twits troll bots are worse than $RDDT

0 · Reply

diagio Nov. 7 at 1:07 AM

$BURU $ADAPY $INTS Another winner here, pumping fabulous garbage like $ACON and $SUNE 🤣

3 · Reply

Rony4AM Nov. 6 at 11:08 PM

$ACON

0 · Reply

Rony4AM Nov. 6 at 11:08 PM

$ACON

0 · Reply

Tellsome1 Nov. 6 at 11:05 PM

$ACON earnings next week...

0 · Reply

TurskaInTar Nov. 6 at 9:12 PM

$ACON bid 7.50 ask 8.24, and the SP hammered all the time close to the bid, manipulated maybe 🫠🥱

0 · Reply

TurskaInTar Nov. 5 at 4:55 PM

$ACON Holding

0 · Reply

PiratesKingLuffy Nov. 5 at 5:32 AM

Looking for the next parabolic runner?? Make sure to keep eyes on ticker VEEE .💎 VEEE catching serious attention after that $4.X.25M property sale. Tiny float✅ Clean balance sheet✅ Not many tickers trading under $3.X with real assets and no debt VEE is one💎 The setup here is one of a kind, this has the look to go massive. Make sure not to miss out tomorrow bulls! . $HCWC $ACON $HTCO $PRHI ./

0 · Reply

Schizoo Nov. 3 at 7:27 PM

$ACON🤌

0 · Reply

Schizoo Nov. 3 at 4:34 PM

$ACON

0 · Reply

makedatbread88 Nov. 3 at 3:51 AM

$ACON low floater right at support any news sends it

0 · Reply

Market Cap	4.02M
Revenue (ttm)	50,000.00
Net Income (ttm)	-6.99M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-13,980.00%
Debt to Equity Ratio	0.00

Volume	23,696
Avg Vol	172,584
Day's Range	N/A - N/A
Shares Out	582,000.00
Stochastic %K	0%
Beta	1.42
Analysts	Sell
Price Target	$22.00